Drug
Mexiletine Granules For Prolonged Release
Mexiletine Granules For Prolonged Release: highest development phase Phase 3, developed by Lupin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mexiletine granules for prolonged-release oral suspension NCT06549400 | Phase 3 | Myotonic Dystrophy |
| Mexiletine granules for prolonged-release oral suspension NCT06523400 | Phase 3 | Myotonic Dystrophy |
Latest
No recent events.
Follow Mexiletine Granules For Prolonged Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.